Patent · US Active

Use of azapaullones for preventing and treating pancreatic autoimmune disorders

US7968535B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignees

DeveloGen Aktiengesellschaft · DE
Technische Universitaet Carolo-Wilhelmina zu Braunschweig · DE

Inventors

Rainer Mussmann · Oebisfelde, DE
Conrad Kunick · Hamburg, DE
Hendrik Stukenbrock · Braunschweig, DE
Marcus Geese · Oettingen, DE
Simone Kegel · Uslar, DE
Ulrike Burk · Oebisfelde, DE

Key dates

Filing date	May 4, 2006
Grant date	Jun 28, 2011
Priority date	—
Expiry date	Sep 13, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to the use of azapaullones, particularly in combination with immunomodulating agents, in the prevention, and/or treatment of pancreatic autoimmune disorders, e.g. type I diabetes or LADA and neurodegenerative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.